Table 1.

Randomized clinical trials of autologous HSCT in autoimmune disease

Randomized clinical trials of autologous HSCT in autoimmune disease

CYC, indicates cyclophosphamide; IVI, intravenous infusion.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal